Patient Guide: Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05862012
Status: 🟢 Enrolling Now
Condition: Relapsed/Refractory Multiple Myeloma
Phase: PHASE1

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Palo Alto, California
  • • Chicago, Illinois
  • • The Bronx, New York
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) - Join Clinical Trial NCTNCT05862012

How to Join This Clinical Trial - NCTNCT05862012

Learn how to participate in this PHASE1 trial studying an investigational therapy for Relapsed/Refractory Multiple Myeloma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsed/Refractory Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsed/Refractory Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05862012 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: RECRUITING

Clinical Research Site

The Bronx, New York 10467 - United States

Status: RECRUITING

Clinical Research Site

Chapel Hill, North Carolina 27599 - United States

Status: RECRUITING

Clinical Research Site

Milwaukee, Wisconsin 53226 - United States

Status: RECRUITING

Clinical Research Site

Concord, New South Wales 2139 - Australia

Status: RECRUITING

Clinical Research Site

Benowa, Queensland 4217 - Australia

Status: RECRUITING

Clinical Research Site

Fitzroy, Victoria 3065 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3000 - Australia

Status: RECRUITING

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Relapsed/Refractory Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships